Our laboratory has a section devoted to support of epidemiological investigations of cancer risk in relationship to circulating hormone levels. We have an expertise in assay of analytes related to insulin-like growth factor physiology, insulin resistance, and other hormonal pathways implicated in carcinogenesis. We provide a service to leading epidemiologic groups including Harvard University, Johns Hopkins University, the National Cancer Institute (USA), the American Cancer Society, and others in this area.
